|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/437 | |
| A61K 31/519 | |||
| A61K 31/5377 | |||
| A61P 35/00 | |||
| A61K 31/5025 | |||
| A61K 31/53 | |||
| A61K 31/506 | |||
| A61K 31/47 | |||
| A61K 31/496 | |||
| A61K 31/404 | |||
| A61K 31/44 |
| (11) | Patento numeris | 3023100 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14826652.1 |
| Europos patento paraiškos padavimo data | 2014-07-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-05-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-03-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2014/069086 |
| Data | 2014-07-17 |
| (87) | Numeris | WO 2015/008839 |
| Data | 2015-01-22 |
| (30) | Numeris | Data | Šalis |
| 2013149963 | 2013-07-18 | JP |
| (72) |
OCHIIWA, Hiroaki, JP
HIRAI, Hiroshi, JP
|
| (73) |
Taiho Pharmaceutical Co., Ltd.,
27, Kandanishiki-cho 1-chome Chiyoda-ku, Tokyo 101-8444,
JP
|
| (54) | ANTITUMOR DRUG FOR INTERMITTENT ADMINISTRATION OF FGFR INHIBITOR |
| ANTITUMOR DRUG FOR INTERMITTENT ADMINISTRATION OF FGFR INHIBITOR |